H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects.
about
Sphingolipids: a potential molecular approach to treat allergic inflammationOral antihistamines for seasonal allergic conjunctivitisPharmacology of antihistaminesCrystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptorSelective inhibitors of CYP2J2 related to terfenadine exhibit strong activity against human cancers in vitro and in vivoAntihistaminic, anti-inflammatory, and antiallergic properties of the nonsedating second-generation antihistamine desloratadine: a review of the evidencePharmacological Management of Allergic Rhinitis in the ElderlyHistamine induces postprandial tachycardia through a direct effect on cardiac H2-receptors in pythons.Vascular effects of diphenylmethoxypiperidine-derived dopamine uptake inhibitors.No cardiac effects of therapeutic and supratherapeutic doses of rupatadine: results from a 'thorough QT/QTc study' performed according to ICH guidelines.Chronic ingestion of H1-antihistamines increase progression of atherosclerosis in apolipoprotein E-/- mice.Histamine in the regulation of wakefulness.Inverse agonism and its therapeutic significance.Pharmacology of antihistamines.Vascular responses in the skin: an accessible model of inflammation.Inverse agonist and pharmacochaperone properties of MK-0524 on the prostanoid DP1 receptorFexofenadine: biochemical, pharmacokinetic and pharmacodynamic properties and its unique role in allergic disorders.Effects of antihistamine and anti-inflammatory medication use on risk of specific glioma histologies.Actual therapeutic management of allergic and hyperreactive nasal disordersTransporter-mediated Efflux Influences CNS Side Effects: ABCB1, from Antitarget to Target.The ARIA/EAACI criteria for antihistamines: an assessment of the efficacy, safety and pharmacology of desloratadine.Anti-inflammatory properties of desloratadine.Dimebon slows progression of proteinopathy in γ-synuclein transgenic mice.Histamine in allergic inflammation and immune modulation.Antihistamines in dermatology.In Vivo Anti-Inflammatory Effect of H1 Antihistamines in Allergic Rhinitis: A Randomized Clinical Trial.Anaphylaxis audit in a busy metropolitan Emergency Department: a review of real life management compared to best practiceCase files of the medical toxicology fellowship at Drexel University. Rhabdomyolysis and compartment syndrome following acute diphenhydramine overdosePharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN).Challenges in the management of chronic urticaria.Pharmacotherapy for allergic contact dermatitis.QT interval prolongation and torsade de pointes: Synergistic effect of flecainide and H1 receptor antagonists.A review of the role of levocetirizine as an effective therapy for allergic disease.Allergic rhinitis: epidemiological aspects, diagnosis and treatment.Therapeutic management of allergic diseases.Histamine H1-receptor antagonists with immunomodulating activities: potential use for modulating T helper type 1 (Th1)/Th2 cytokine imbalance and inflammatory responses in allergic diseases.Levocetirizine in the treatment of allergic diseases.Efficacy of dimetinden and hydroxyzine/chlorpheniramine in atopic dogs: a randomised, controlled, double-blinded trial.Pharmacological significance of triazole scaffold.Drugs with anticholinergic properties: a current perspective on use and safety.
P2860
Q21296721-54EFEF3A-D765-4C86-91CA-6AE5AE19BBA4Q24194291-15EF785B-14F5-4970-A314-2A62D7D7E455Q24618798-5D485F03-F391-478B-8FD3-5C6272281C93Q24633082-6460F58B-B669-4CC0-91DF-B1DCD9E721AAQ28238324-CBA61852-730F-4DB0-81AD-748AF6789820Q28282236-A8E235F6-A385-43C8-BDDD-22D57AD0D8D3Q30240237-3344A044-BDD8-49DD-969E-9EECE7EF26B3Q33394132-70A247DA-1A09-4D48-A2CB-2117DFC3F799Q33750623-93E407F5-B130-4AAB-814B-220F0AC813EDQ33765011-5F0F1A41-65A8-4B06-9324-04946459A88AQ33895956-45BEBB91-61DC-45AE-9349-99487B1EF0E0Q34138704-EE2E4E9B-93E3-4871-9D41-5B2F6B7AB280Q34226789-7EB474FE-8EED-446B-9137-DF08D85A19DEQ34347782-A41DAE29-D103-463D-BB77-14977F5F66EFQ34756697-1594F24E-D516-43C3-9D12-F0DF4385BF2BQ34770179-A0788203-D0E8-4E5C-8B9D-A73969CCBE3FQ34988193-234B86B8-6FB1-4490-ACE8-D1A8347773FCQ35074801-6EAEBAD3-DF84-4C45-B42B-288ECA9DA69BQ35427205-D9B6468C-0F3D-4D63-BD49-6F0252A969D8Q35761679-E1F28CE4-457A-4EAE-A9BD-C53E3EB757C0Q35827475-62D3642A-C3DF-4B76-B976-F8592A084557Q35878377-21B69F6C-02B9-460D-A1DC-09AEDC89F226Q35957568-7CFD2EC0-9AEE-4D73-92E8-7BF9FC9E3E97Q36098788-20279BBC-2DD3-4ED0-8329-F06DD5A4F4A3Q36193211-8EE22ED4-A8B7-4CCA-AC64-AE669461C70BQ36407643-73EB73CD-3E7A-42F6-AFD6-AA89801E45DFQ36516139-DF6B92AB-D987-4AE9-9345-7A2777EB4FEAQ36548902-CDE6609A-51CB-4AEE-B05C-84B44E6927E6Q36570549-1E1B0ABA-102C-448F-98C9-8F9E6C238A23Q36882652-8B03601A-A539-4CB4-8BC5-39B418184B3FQ36979315-F2E3A97B-552E-42F9-9CE1-2F4ADE72BC4DQ37073199-F178B0CE-AF92-488E-9F14-F6F9998A1699Q37111873-8A068E8E-2DA1-496D-A873-AE992542EA6FQ37143174-4A973445-66A8-4B06-ADFF-079E58255431Q37550543-3F66C898-B24F-4B2B-887A-AB1753A886B1Q37573980-8A11A7C5-B37A-4A99-8F10-AC17B366992EQ37575658-1CE759A8-AEC1-40B1-8DDC-0ACCA1E10098Q37576555-BA84F7FC-86AC-416A-A70E-2C7F86EF931FQ37768161-3CF32282-69AC-4415-B3B9-1637AB34747FQ37884068-4E368DE1-2D81-4580-A6D9-1BDBAE80B51F
P2860
H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects.
@ast
H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects.
@en
H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects.
@nl
type
label
H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects.
@ast
H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects.
@en
H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects.
@nl
prefLabel
H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects.
@ast
H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects.
@en
H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects.
@nl
P2093
P2860
P1476
H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects.
@en
P2093
M K Church
M Taglialatela
P2860
P304
P356
10.1046/J.0954-7894.2002.01314.X
P577
2002-04-01T00:00:00Z